In recent trading session, Merck & Co Inc (NYSE:MRK) saw 2.87 million shares changing hands at last check today with its beta currently measuring 0.39. Company’s recent per share price level of $75.58 trading at $0.78 or 1.04% at last check today assigns it a market valuation of $189.78B. That most recent trading price of MRK’s stock is at a discount of -78.13% from its 52-week high price of $134.63 and is indicating a premium of 3.0% from its 52-week low price of $73.31.
For Merck & Co Inc (MRK), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.92. Splitting up the data highlights that, out of 19 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 19 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Merck & Co Inc (NYSE:MRK) trade information
Upright in the green today for gaining 1.04%, in the last five days MRK remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $75.58 price level, adding 7.0% to its value on the day. Merck & Co Inc’s shares saw a change of -24.02% in year-to-date performance and have moved -0.51% in past 5-day. Merck & Co Inc (NYSE:MRK) showed a performance of -1.15% in past 30-days.
Wall Street analysts have assigned a consensus price target of 106 to the stock, which implies a rise of 28.7% to its recent value today. Analysts have been projecting 82 as a low price target for the stock while placing it at a high target of 110. It follows that stock’s current price would drop -8.49% in reaching the projected high whereas dropping to the targeted low would mean a loss of -8.49% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.04% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 16.48% while estimates for its earnings growth in next 5 years are of 11.65%.
Merck & Co Inc (NYSE:MRK)’s Major holders
VANGUARD GROUP INC is the top institutional holder at MRK for having 244.68 million shares of worth $30.29 billion. And as of 2024-06-30, it was holding 9.6558 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 207.3 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.1806 of outstanding shares, having a total worth of $25.66 billion.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 79.26 shares of worth $6.0 billion or 3.16% of the total outstanding shares. The later fund manager was in possession of 68.48 shares on Dec 31, 2024 , making its stake of worth around $5.18 billion in the company or a holder of 2.73% of company’s stock.
